The 2026 Community Practice Innovation Award supports projects that enhance care delivery, improve outcomes and address real-world challenges in rheumatology.
The ACR recently led a rheumatology community letter to Cigna opposing the payer’s decision to downcode level 4 and 5 evaluation and management claims.
All vaccines recommended by the CDC’s ACIP as of Sept. 1, 2025—including updated COVID-19 and influenza shots—will be covered by health plans with no cost sharing for patients through the end of 2026.